OTCMOPTHF
Market cap13mUSD
Jan 10, Last price
0.14USD
1D
-2.55%
1Q
-5.80%
IPO
-74.87%
Name
Optimi Health Corp
Chart & Performance
P/E
—
P/S
106.53
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
181k
+124.35%
Net income
-5m
L-29.33%
CFO
-4m
L-21.36%
Profile
Optimi Health Corp. develops an integrated functional mushroom brand that focuses on the health and wellness food markets in Canada. The company also focuses on the cultivation, extraction, processing, and distribution of strains of functional mushroom. It offers a range of fungi varieties, which include Lions Mane, Reishi, Turkey Tail, Chaga, and Cordyceps. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is headquartered in Vancouver, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | |
| Income | ||||
Revenues | 181 124.35% | 81 | ||
Cost of revenue | 4,424 | 7,177 | ||
Unusual Expense (Income) | ||||
NOPBT | (4,243) | (7,096) | ||
NOPBT Margin | ||||
Operating Taxes | 65 | |||
Tax Rate | ||||
NOPAT | (4,243) | (7,161) | ||
Net income | (5,195) -29.33% | (7,351) 22.12% | ||
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | 1,844 | 1,298 | ||
BB yield | ||||
| Debt | ||||
Debt current | 37 | 88 | ||
Long-term debt | 1,740 | 227 | ||
Deferred revenue | ||||
Other long-term liabilities | ||||
Net debt | 432 | (1,573) | ||
| Cash flow | ||||
Cash from operating activities | (3,602) | (4,580) | ||
CAPEX | (804) | (7,151) | ||
Cash from investing activities | (706) | (3,151) | ||
Cash from financing activities | 3,764 | 1,187 | ||
FCF | (3,902) | (12,645) | ||
| Balance | ||||
Cash | 1,345 | 1,889 | ||
Long term investments | ||||
Excess cash | 1,336 | 1,885 | ||
Stockholders' equity | 13,211 | 16,020 | ||
Invested Capital | 13,582 | 14,293 | ||
ROIC | ||||
ROCE | ||||
| EV | ||||
Common stock shares outstanding | 86,983 | 77,940 | ||
Price | ||||
Market cap | ||||
EV | ||||
EBITDA | (3,513) | (6,803) | ||
EV/EBITDA | ||||
Interest | 44 | 28 | ||
Interest/NOPBT | ||||